AlphaFold predicted structure
EYA4 · O95677

Mean pLDDT
62.7/ 100
Low
639 residues
Confidence breakdown
- Very high(≥ 90)39%
- Confident(70–90)1%
- Low(50–70)3%
- Very low(< 50)56%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
EYA transcriptional coactivator and phosphatase 4
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Monogenic hearing loss
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedDilated and arrhythmogenic cardiomyopathy
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedDilated Cardiomyopathy and conduction defects
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedPaediatric or syndromic cardiomyopathy
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedautosomal dominant nonsyndromic hearing loss 10
dilated cardiomyopathy 1J
hearing loss disorder
presbycusis
Sensorineural hearing impairment
deafness
Abnormality of the cardiovascular system
autosomal dominant nonsyndromic hearing loss
atrial fibrillation
Sensorineural deafness with dilated cardiomyopathy
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Protein phosphatase EYA4
Tyrosine phosphatase that specifically dephosphorylates 'Tyr-142' of histone H2AX (H2AXY142ph). 'Tyr-142' phosphorylation of histone H2AX plays a central role in DNA repair and acts as a mark that distinguishes between apoptotic and repair responses to genotoxic stress. Promotes efficient DNA repair by dephosphorylating H2AX, promoting the recruitment of DNA repair complexes containing MDC1. Its function as histone phosphatase probably explains its role in transcription regulation during organogenesis. May be involved in development of the eye (By similarity)
Curated MONDO disease pages that list EYA4 among their top associated genes.
EYA4 · O95677

Mean pLDDT
62.7/ 100
Low
639 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0